Eli Lilly’s obesity pill remains a viable rival to Novo’s oral Wegovy despite data that underwhelmed investors August 24, 2025 John Cooper Global Market No comments yet **Eli Lilly’s Orforglipron: A Game-Changer in the Diabetes Treatment market?** The diabetes treatment market is heating up, with pharmaceutical giant… Read more
Viking Therapeutics shares fall 40% on disappointing obesity pill trial data August 19, 2025 John Cooper Global Market No comments yet **Weight Loss and Diabetes Drug market: Eli Lilly and Novo Nordisk Poised to Strengthen Dominance** The pharmaceutical industry is abuzz with anticip… Read more
China Hits Back After US Warning on Toxic Mine Spill in Zambia August 18, 2025 John Cooper Global Market No comments yet **Copper Mine Disaster Sparks Diplomatic Row: What It Means for Investors** **A Warning from the US Embassy in Zambia** In a rare move, the US embas… Read more